Search results
10 Best Growing Industries To Invest in for 2024
GoBankingRates via AOL· 2 days agoThe Pharmaceutical Manufacturing Market is expected to reach $967.12 billion in size by 2029, representing a CAGR of 12.14%. Here are some of the biggest...
This Stock Has Gained 150% Since I Bought It – but It Could Still Be a Bargain | The Motley Fool
The Motley Fool· 2 days agoI bought this bank stock during the initial COVID-19 crash, and I'm sure glad I did.
3 Blue-Chip Stocks to Buy on the Dip: May 2024
InvestorPlace· 7 days agoWhile the latest Commerce Department report showed a notable deceleration in GDP growth, experts attribute much of this to robust spending on imported...
The Savvy Investor's Cheat Sheet: 3 Deep Value Picks for May 2024
InvestorPlace· 5 days agoChubb Limited (NYSE:CB) is an insurance firm that was spotlighted when it was revealed that...
Guardant Health Rises On A Key Colon Cancer Win; Exact Sciences Dips
Investor's Business Daily· 3 days agoThe FDA's Medical Devices Advisory Committee voted eight to one that Guardant's blood-based test,...
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 6 days agoShares of vaccine producers' stocks are trading higher Wednesday on reports indicating disease...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA TODAY via Yahoo News· 6 days ago“Health centers will either stock these vaccines or refer to resources within their community – with...
Is the SCHG a good complement to the SCHD ETF?
Invezz· 5 days agoThe Schwab US Large-Growth ETF (SCHG) continued its remarkable rally this week as it jumped to its highest level on record. It has jumped by over 82%...
GSK’s New Vaccine Kept the Boss in Her Job — and an Activist at Bay
Bloomberg via Yahoo Finance· 7 days ago(Bloomberg) -- When Elliott Investment Management came calling for the ouster of Emma Walmsley, the...
Better Buy: Inovio Pharmaceuticals vs. Novavax | The Motley Fool
The Motley Fool· 6 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of...
